Concord Drugs Share Price Today | Stock Price & Concord Drugs Share Screener

Track the current stock price of Concord Drugs with an interactive chart. Analyse CONCORD share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Concord Drugs stock quote in one place.

The quote of ₹76.92 sits between the 52-week low of ₹65.07 and the 52-week high of ₹90.08, and the latest session moved 1.61% from the previous close.

Screen Concord Drugs company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for CONCORD shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE858L01010.

Classification

Identifiers and Leadership

Screen CONCORD balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹75, up from ₹65 in 2025.

Latest statistics put total assets at ₹75 and shareholder funds at ₹49, with a leverage ratio of 0.41.

Screen Concord Drugs income statement and profit fundamentals. Analyze CONCORD quarterly results. Concord Drugs reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Jun, revenue was ₹21 and net profit was ₹1, equal to earnings per unit of ₹0.85, at an operating margin of 11%.

In that period expenses were ₹19, interest cost ₹0 and tax ₹0. The next period listed, 2026-Mar, shows revenue of ₹38 and net profit of ₹1.

Screen CONCORD cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities used ₹6.

Over the same period, investing activities used ₹1 and financing activities provided ₹7.

See Concord Drugs shareholding pattern with promoter, FII, and DII holdings. Check Concord Drugs promoter holding and ownership changes for CONCORD on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Jun, promoters held 45.08%, foreign institutions 0.00%, domestic institutions 0.00% and the public 54.19%, spread across 4,435 shareholders.

The shareholder count was 4,435 in 2026-Jun, compared with 4,464 in 2026-Mar.

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Concord Drugs. Concord Drugs dividend yield can be compared with peers and other stocks in the market.

See which indices include Concord Drugs stock. Check CONCORD index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Get Concord Drugs corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Concord Drugs stock events that may affect CONCORD share price, along with derivatives, futures and options activity and sector gainers.

13 corporate actions are listed, the most recent entry being Annual General Meeting dated September 30, 2026, with a record date of September 30, 2026.

It is followed by Quarterly Result Announcement dated August 10, 2026 and Quarterly Result Announcement dated May 27, 2026.

Screen CONCORD competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Screen CONCORD latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 3, 2026.

The next most recent announcements are dated September 9, 2026 and September 7, 2026.

Quotes are sourced from the BSE. Key statistics were last updated on October 6, 2026. This page covers 5 balance sheet periods, 15 income statement periods, 5 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.